SG11202105465WA - 2-fluorinated bile acids for the treatment of neurodegenerative diseases - Google Patents

2-fluorinated bile acids for the treatment of neurodegenerative diseases

Info

Publication number
SG11202105465WA
SG11202105465WA SG11202105465WA SG11202105465WA SG11202105465WA SG 11202105465W A SG11202105465W A SG 11202105465WA SG 11202105465W A SG11202105465W A SG 11202105465WA SG 11202105465W A SG11202105465W A SG 11202105465WA SG 11202105465W A SG11202105465W A SG 11202105465WA
Authority
SG
Singapore
Prior art keywords
compound
general formula
dihydroxy
difluoro
acid
Prior art date
Application number
SG11202105465WA
Other languages
English (en)
Inventor
Alexander Weymouth-Wilson
Bruno Jan Pol Linclau
Gemma Packer
Joseph WATTS
Heather Mortiboys
Oliver Bandmann
Christopher Hastings
Original Assignee
Nzp Uk Ltd
The Univ Of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nzp Uk Ltd, The Univ Of Southampton filed Critical Nzp Uk Ltd
Publication of SG11202105465WA publication Critical patent/SG11202105465WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11202105465WA 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases SG11202105465WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1820887.6A GB201820887D0 (en) 2018-12-20 2018-12-20 Compounds
PCT/GB2019/053665 WO2020128514A1 (en) 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
SG11202105465WA true SG11202105465WA (en) 2021-06-29

Family

ID=65364420

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202105465WA SG11202105465WA (en) 2018-12-20 2019-12-20 2-fluorinated bile acids for the treatment of neurodegenerative diseases

Country Status (15)

Country Link
US (1) US20220073557A1 (cg-RX-API-DMAC7.html)
EP (1) EP3898645B1 (cg-RX-API-DMAC7.html)
JP (1) JP7503063B2 (cg-RX-API-DMAC7.html)
KR (1) KR102856276B1 (cg-RX-API-DMAC7.html)
CN (1) CN113330020B (cg-RX-API-DMAC7.html)
AU (1) AU2019411556B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021011189A2 (cg-RX-API-DMAC7.html)
CA (1) CA3123333A1 (cg-RX-API-DMAC7.html)
EA (1) EA202191521A1 (cg-RX-API-DMAC7.html)
ES (1) ES3036094T3 (cg-RX-API-DMAC7.html)
GB (1) GB201820887D0 (cg-RX-API-DMAC7.html)
IL (1) IL284093B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021007551A (cg-RX-API-DMAC7.html)
SG (1) SG11202105465WA (cg-RX-API-DMAC7.html)
WO (1) WO2020128514A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4486318A4 (en) * 2022-03-02 2026-02-25 Boyce Thompson Institute For Plant Res Inc Cysteamides, related therapeutic compositions and associated processes
GB202208151D0 (en) 2022-06-01 2022-07-13 Nzp Uk Ltd Compounds
GB202314563D0 (en) 2023-09-22 2023-11-08 Nzp Uk Ltd Compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9509764A (pt) * 1994-11-23 1998-07-07 Cocensys Inc Série androstano e pregnano para modulação alostérica de receptor de gaba
AU3967297A (en) * 1996-08-01 1998-02-25 Cocensys, Inc. Use of gaba and nmda receptor ligands for the treatment of migraine headache
FR2934596B1 (fr) * 2008-07-30 2015-04-10 Trophos Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
ITMI20121344A1 (it) * 2012-07-31 2014-02-01 Erregierre Spa Processo di preparazione di acido ursodesossicolico ad elevata purezza
WO2014036379A2 (en) * 2012-08-31 2014-03-06 Metselex Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases
CN103333216A (zh) * 2013-06-04 2013-10-02 苏州大学 5α-6-酮-胆甾烷类似物及其应用
US20150112089A1 (en) 2013-10-22 2015-04-23 Metselex, Inc. Deuterated bile acids
CN107531741A (zh) * 2015-03-10 2018-01-02 美莱斯股份有限公司 氟化和烷基化胆酸
GB201812382D0 (en) * 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds

Also Published As

Publication number Publication date
WO2020128514A1 (en) 2020-06-25
EP3898645C0 (en) 2025-06-25
CA3123333A1 (en) 2020-06-25
MX2021007551A (es) 2021-10-13
JP7503063B2 (ja) 2024-06-19
ES3036094T3 (en) 2025-09-12
GB201820887D0 (en) 2019-02-06
CN113330020A (zh) 2021-08-31
EP3898645A1 (en) 2021-10-27
AU2019411556A1 (en) 2021-06-10
IL284093B2 (en) 2025-07-01
IL284093B1 (en) 2025-03-01
JP2022514401A (ja) 2022-02-10
BR112021011189A2 (pt) 2021-08-31
KR102856276B1 (ko) 2025-09-05
AU2019411556B2 (en) 2025-04-03
EA202191521A1 (ru) 2021-09-10
US20220073557A1 (en) 2022-03-10
CN113330020B (zh) 2024-04-05
IL284093A (en) 2021-08-31
EP3898645B1 (en) 2025-06-25
KR20210125982A (ko) 2021-10-19

Similar Documents

Publication Publication Date Title
IL265902A (en) Complex mixtures containing cannabinoids for the treatment of neurodegenerative diseases
IL254288B (en) C22-, c23- and c24-amino-carbonyl-oxy derivatives of bile acids and their use for treating tgr5-mediated diseases
EP3227330A4 (en) Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
SMT201900172T1 (it) Ammino triazoli sostituiti utili come inibitori della chitinasi umana
IL269106A (en) Methods for the treatment of neurodegenerative diseases
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
SG11202006374VA (en) Treatment of demyelinating diseases
IL282361A (en) Treatment for neurological diseases
ZA202101587B (en) Protein for treatment of inflammatory diseases
IL273929A (en) Therapeutic agents for neurodegenerative diseases
ZA201805407B (en) Composition for the prevention or treatment of neurodegenerative diseases.
GB201805100D0 (en) Treatment of sarcopenic diseases
PL3603621T3 (pl) Liposomy do leczenia chorób oczu
EP3634394A4 (en) COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
HUE069820T2 (hu) Nalfurafin alkalmazása demielinizációs betegségek kezelésére
IL284093A (en) 2-fluorinated bile acids for the treatment of neurodegenerative diseases
IL280441A (en) Sulfopropanoic acid derivatives for treating neurodegenerative disorders
GB201714307D0 (en) Treatment of neurodegenerative diseases
EP3755334A4 (en) TREATMENT OF LIVER DISEASES
EP3283457A4 (en) Compounds and methods for the treatment of neurodegenerative diseases
HUE069327T2 (hu) Neurodegeneratív betegségek megelõzésére vagy kezelésére szolgáló gyógyszer
PL3733684T3 (pl) Pochodne kwasu ursodeoksycholowego do leczenia wielotorbielowatości
GB201714303D0 (en) Treatment of neurodegenerative diseases
EP3534954A4 (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
KR102324922B9 (ko) 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물